Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
7024 | 1415 | 45.6 | 85% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
54 | 3 | ASTHMA//RESPIRATORY SYSTEM//ALLERGY | 90590 |
112 | 2 | ASTHMA//EOSINOPHILS//ALLERGY | 25091 |
7024 | 1 | SEVERE ASTHMA//INDUCED SPUTUM//SPUTUM CELL COUNTS | 1415 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | SEVERE ASTHMA | authKW | 1014357 | 9% | 36% | 131 |
2 | INDUCED SPUTUM | authKW | 900737 | 11% | 27% | 154 |
3 | SPUTUM CELL COUNTS | authKW | 442013 | 2% | 79% | 26 |
4 | BRONCHIAL THERMOPLASTY | authKW | 433759 | 2% | 72% | 28 |
5 | ASTHMA PHENOTYPES | authKW | 296774 | 2% | 51% | 27 |
6 | ENDOTYPE | authKW | 260233 | 2% | 43% | 28 |
7 | MEPOLIZUMAB | authKW | 247205 | 2% | 44% | 26 |
8 | BENRALIZUMAB | authKW | 243110 | 1% | 87% | 13 |
9 | ASTHMA | authKW | 224566 | 38% | 2% | 539 |
10 | RESLIZUMAB | authKW | 222588 | 1% | 74% | 14 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Allergy | 67397 | 32% | 1% | 456 |
2 | Respiratory System | 41135 | 44% | 0% | 626 |
3 | Immunology | 6693 | 34% | 0% | 475 |
4 | Critical Care Medicine | 4250 | 11% | 0% | 155 |
5 | Medicine, General & Internal | 268 | 8% | 0% | 113 |
6 | Medicine, Research & Experimental | 68 | 4% | 0% | 54 |
7 | Pharmacology & Pharmacy | 55 | 6% | 0% | 91 |
8 | Pediatrics | 46 | 3% | 0% | 43 |
9 | Cardiac & Cardiovascular System | 32 | 3% | 0% | 46 |
10 | Medical Laboratory Technology | 1 | 0% | 0% | 6 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | LUNG HLTH | 127337 | 4% | 11% | 56 |
2 | PRIOR INFORMAT BASED MED | 89907 | 0% | 83% | 5 |
3 | PULM ALLERG DIS | 83673 | 1% | 24% | 16 |
4 | FI TONE P HLTH | 77335 | 3% | 9% | 39 |
5 | P THER EUT UNIT | 69048 | 0% | 80% | 4 |
6 | FI TONE REG CHEST ALLERGY UNIT | 57531 | 1% | 33% | 8 |
7 | P SLEEP MED | 50842 | 3% | 5% | 45 |
8 | EXCELLENCE SEVERE ASTHMA | 48549 | 0% | 75% | 3 |
9 | ASTHMA GRP | 46163 | 1% | 13% | 17 |
10 | PRIOR ASTHMA P DIS | 43577 | 1% | 14% | 14 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 32870 | 9% | 1% | 127 |
2 | EUROPEAN RESPIRATORY JOURNAL | 23765 | 7% | 1% | 100 |
3 | CLINICAL AND EXPERIMENTAL ALLERGY | 19106 | 5% | 1% | 67 |
4 | CURRENT OPINION IN PULMONARY MEDICINE | 16812 | 2% | 3% | 31 |
5 | AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 14947 | 6% | 1% | 82 |
6 | EXPERT REVIEW OF RESPIRATORY MEDICINE | 14886 | 1% | 4% | 17 |
7 | CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY | 13989 | 2% | 3% | 26 |
8 | LANCET RESPIRATORY MEDICINE | 11837 | 1% | 5% | 12 |
9 | CANADIAN RESPIRATORY JOURNAL | 10372 | 1% | 3% | 16 |
10 | RESPIRATORY MEDICINE | 8231 | 3% | 1% | 45 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | SEVERE ASTHMA | 1014357 | 9% | 36% | 131 | Search SEVERE+ASTHMA | Search SEVERE+ASTHMA |
2 | INDUCED SPUTUM | 900737 | 11% | 27% | 154 | Search INDUCED+SPUTUM | Search INDUCED+SPUTUM |
3 | SPUTUM CELL COUNTS | 442013 | 2% | 79% | 26 | Search SPUTUM+CELL+COUNTS | Search SPUTUM+CELL+COUNTS |
4 | BRONCHIAL THERMOPLASTY | 433759 | 2% | 72% | 28 | Search BRONCHIAL+THERMOPLASTY | Search BRONCHIAL+THERMOPLASTY |
5 | ASTHMA PHENOTYPES | 296774 | 2% | 51% | 27 | Search ASTHMA+PHENOTYPES | Search ASTHMA+PHENOTYPES |
6 | ENDOTYPE | 260233 | 2% | 43% | 28 | Search ENDOTYPE | Search ENDOTYPE |
7 | MEPOLIZUMAB | 247205 | 2% | 44% | 26 | Search MEPOLIZUMAB | Search MEPOLIZUMAB |
8 | BENRALIZUMAB | 243110 | 1% | 87% | 13 | Search BENRALIZUMAB | Search BENRALIZUMAB |
9 | ASTHMA | 224566 | 38% | 2% | 539 | Search ASTHMA | Search ASTHMA |
10 | RESLIZUMAB | 222588 | 1% | 74% | 14 | Search RESLIZUMAB | Search RESLIZUMAB |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | SEYS, SF , (2017) ROLE OF SPUTUM BIOMARKERS IN THE MANAGEMENT OF ASTHMA.CURRENT OPINION IN PULMONARY MEDICINE. VOL. 23. ISSUE 1. P. 34 -40 | 70 | 81% | 0 |
2 | SCHLEICH, F , SOPHIE, D , RENAUD, L , (2016) BIOMARKERS IN THE MANAGEMENT OF DIFFICULT ASTHMA.CURRENT TOPICS IN MEDICINAL CHEMISTRY. VOL. 16. ISSUE 14. P. 1561 -1573 | 75 | 63% | 2 |
3 | CHUNG, KF , WENZEL, SE , BROZEK, JL , BUSH, A , CASTRO, M , STERK, PJ , ADCOCK, IM , BATEMAN, ED , BEL, EH , BLEECKER, ER , ET AL (2014) INTERNATIONAL ERS/ATS GUIDELINES ON DEFINITION, EVALUATION AND TREATMENT OF SEVERE ASTHMA.EUROPEAN RESPIRATORY JOURNAL. VOL. 43. ISSUE 2. P. 343 -373 | 68 | 33% | 262 |
4 | FAJT, ML , WENZEL, SE , (2015) ASTHMA PHENOTYPES AND THE USE OF BIOLOGIC MEDICATIONS IN ASTHMA AND ALLERGIC DISEASE: THE NEXT STEPS TOWARD PERSONALIZED CARE.JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. VOL. 135. ISSUE 2. P. 299 -311 | 52 | 50% | 62 |
5 | SKLOOT, GS , (2016) ASTHMA PHENOTYPES AND ENDOTYPES: A PERSONALIZED APPROACH TO TREATMENT.CURRENT OPINION IN PULMONARY MEDICINE. VOL. 22. ISSUE 1. P. 3 -9 | 44 | 76% | 5 |
6 | CHUNG, KF , (2015) TARGETING THE INTERLEUKIN PATHWAY IN THE TREATMENT OF ASTHMA.LANCET. VOL. 386. ISSUE 9998. P. 1086 -1096 | 45 | 63% | 32 |
7 | CHUNG, KF , (2014) DEFINING PHENOTYPES IN ASTHMA: A STEP TOWARDS PERSONALIZED MEDICINE.DRUGS. VOL. 74. ISSUE 7. P. 719 -728 | 55 | 69% | 12 |
8 | BAKAKOS, P , SCHLEICH, F , ALCHANATIS, M , LOUIS, R , (2011) INDUCED SPUTUM IN ASTHMA: FROM BENCH TO BEDSIDE.CURRENT MEDICINAL CHEMISTRY. VOL. 18. ISSUE 10. P. 1415 -1422 | 67 | 63% | 16 |
9 | CHUNG, KF , (2016) ASTHMA PHENOTYPING: A NECESSITY FOR IMPROVED THERAPEUTIC PRECISION AND NEW TARGETED THERAPIES.JOURNAL OF INTERNAL MEDICINE. VOL. 279. ISSUE 2. P. 192 -204 | 48 | 51% | 10 |
10 | GAUTHIER, M , RAY, A , WENZEL, SE , (2015) EVOLVING CONCEPTS OF ASTHMA.AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. VOL. 192. ISSUE 6. P. 660 -668 | 46 | 61% | 25 |
Classes with closest relation at Level 1 |